SB 1200 — Missouri
Removes the expiration date on certain provisions relating to gender transition
Missouri legislative agenda & upcoming votes Missouri session calendar
Summary
SB 1200 - Currently, a health care provider shall not knowingly prescribe or administer cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for children. This provision of law does not apply to those children who were prescribed or administered such drugs prior to August 28, 2023.
This prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on August 28, 2027. This act removes that expiration date. Additionally, the provision excluding those children already prescribed or administered the hormones or drugs prior to August 28, 2023, from the general prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on March 1, 2027.
This act is substantially similar to HCS/HBs 2033, 1608, 1672, & 1854 (2026), SB 1264 (2026), SB 861 (2026), SB 75 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 249 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024).
SARAH HASKINS
- SB 1200 is a bill in the Missouri Senate, 2026 session, introduced December 1, 2025.
- Sponsored by Brad Hudson.
- Current status: introduced.
- Most recent action (January 27, 2026): Second Read and Referred S Families, Seniors and Health Committee.
- Subjects: Children and Minors, Health Care, Health Care Professionals, Medical Procedures and Personnel.
-
State Senator, District 33
Republican
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: Brad Hudson
History
- Introduced, completed
- Passed Senate, in progress
- Passed House, not reached yet
- Sent to Governor, not reached yet
- Signed into law, not reached yet
- Senate Prefiled
- Senate S First Read
- Senate Second Read and Referred S Families, Seniors and Health Committee Latest